Skip to content

The efficacy and central brain response of the "Zhishen Zhitong" group of acupoints in the treatment of chronic low back pain

The efficacy and central brain response of the "Zhishen Zhitong" group of acupoints in the treatment of chronic low back pain

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084592
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-05-22
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic low back pain

Interventions

control group:Acupuncture at Ashi acupoint
Treatment group:Acupuncture at Ashi acupoints and group acupoints of Zhishen

Sponsors

Yichang Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. Recurrent low back pain for = 3 months; 3. The average pain visual analogue scale (VAS) within the past week was = 3 points; 4. Did not receive any other treatment during the treatment period; 5. Able to understand and willing to sign an informed consent form

Exclusion criteria

Exclusion criteria: 1. Those who are clearly pregnant or suspected to be pregnant; 2. Those who have other primary symptoms that clearly cause pain, anxiety, and depression and require timely treatment; 3. Suffering from other serious diseases, such as various systemic and systemic diseases; 4. Those who have received hormone therapy within the past 3 months; 5. Those who have received any form of pain relief or anti anxiety and depression treatment within the past week; 6. Those who are allergic to acupuncture treatment or have a tendency to bleed; 7. Have received other external treatments within the past week, such as moxibustion, plaster therapy, scraping, massage, physical therapy, etc; 8. Those who have used any investigational drugs or are currently using neuropsychological drugs within the past 30 days; 9. Unable to understand and complete various scales.

Design outcomes

Primary

MeasureTime frame
pain visual analogue scale (VAS);hospital anxiety and depression scale (HADS);head fMRI;

Secondary

MeasureTime frame
insomnia severity index (ISI);other combined treatments;

Countries

China

Contacts

Public Contactanfeng xiang

Yichang Traditional Chinese Medicine Hospital

afxiang0101@163.com+86 159 7166 7172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026